TECX NASDAQ
Tectonic Therapeutic, Inc.
1W: -4.8%
1M: -25.8%
3M: -36.0%
YTD: +7.8%
1Y: +43.9%
3Y: +22.0%
5Y: -68.6%
$22.54
-0.13 (-0.57%)
Weekly Expected Move ±5.2%
$20
$21
$23
$24
$25
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships3
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2023-05-22
Earliest Filing
2024-01-30
Latest Filing
acquirer: 2
target: 1
Counterparties (Filed by TECX)
3 relationshipsCompanies named in TECX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Tectonic Therapeutic, Inc. | TECX | target | Target company in the merger agreement with AVRO, Inc. | 2024-01-30 | View |
| Novartis Pharma AG | NVSEF | acquirer | Purchaser of cystinosis gene therapy program and assets | 2023-05-22 | View |
| Novartis Pharmaceuticals Corporation | NVSEF | acquirer | Purchaser of cystinosis gene therapy program and assets | 2023-05-22 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-29 | Other Events; Exhibits | View | |
| 2026-06-10 | Shareholder Vote; Other Events; Exhibits | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-04-23 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-02-26 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-02-24 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-30 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-07 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-06-06 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-19 | Other Events; Financial Statements and Exhibits | View | |
| 2025-05-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-20 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-03 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2025-01-30 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-01-13 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-11-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-09-19 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-08-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-07-30 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR